EWA
JAZZ icon

EverSource Wealth Advisors’s Jazz Pharmaceuticals JAZZ Stock Holding History

EverSource Wealth Advisors’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$287K Buy
1,520
+739
+95% +$129K 0.01% 864
2025
Q4 		$133K Sell
781
-202
-21% -$31K ﹤0.01% 1165
2025
Q3 		$130K Buy
983
+81
+9% +$9.71K 0.01% 1136
2025
Q2 		$95.7K Buy
902
+313
+53% +$34K ﹤0.01% 1231
2025
Q1 		$73.1K Sell
589
-31
-5% -$4.04K ﹤0.01% 1048
2024
Q4 		$76.4K Buy
620
+305
+97% +$35.9K ﹤0.01% 1008
2024
Q3 		$35.1K Buy
315
+42
+15% +$4.6K ﹤0.01% 1222
2024
Q2 		$30.1K Buy
273
+97
+55% +$10.7K ﹤0.01% 1319
2024
Q1 		$19.5K Buy
176
+67
+61% +$8.21K ﹤0.01% 1375
2023
Q4 		$13.4K Buy
109
+18
+20% +$2.25K ﹤0.01% 1427
2023
Q3 		$11.8K Buy
91
+28
+44% +$3.73K ﹤0.01% 1357
2023
Q2 		$7.81K Sell
63
-3
-5% -$404 ﹤0.01% 1556
2023
Q1 		$9.66K Buy
66
+6
+10% +$888 ﹤0.01% 1376
2022
Q4 		$9.56K Buy
60
+24
+67% +$3.52K ﹤0.01% 1350
2022
Q3 		$5K Hold
36
– – ﹤0.01% 1371
2022
Q2 		$6K Sell
36
-7
-16% -$1.08K ﹤0.01% 1200
2022
Q1 		$7K Sell
43
-5
-10% -$726 ﹤0.01% 1137
2021
Q4 		$6K Buy
+48
New +$6.31K ﹤0.01% 1184

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

EverSource Wealth Advisors's JAZZ Position: Q1 2026 in Review

EverSource Wealth Advisors increased its Jazz Pharmaceuticals (JAZZ) stake by 95% in Q1 2026, buying an estimated $129K and bringing the position to 1,520 shares worth $287K. The position accounts for 0.01% of the portfolio, ranked #864.

EverSource Wealth Advisors first reported a position in JAZZ in Q4 2021 and has held it in 18 quarters since. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • EverSource Wealth Advisors held 1,520 shares of Jazz Pharmaceuticals worth $287K as of Q1 2026.
  • EverSource Wealth Advisors bought 739 Jazz Pharmaceuticals shares in Q1 2026, an estimated $129K.
  • Jazz Pharmaceuticals made up 0.01% of EverSource Wealth Advisors's portfolio in Q1 2026, its #864 holding.
  • EverSource Wealth Advisors first reported a position in Jazz Pharmaceuticals in Q4 2021 and has held it in 18 quarters since.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on EverSource Wealth Advisors's 13F filing for Q1 2026, filed 14 May 2026.